Transcription of AEROSIL® 200 Pharma - Evonik
{{id}} {{{paragraph}}}
Product information AEROSIL 200 PharmaColloidal silicon dioxideEvonik Operations GmbH | Product information AEROSIL 200 Pharma | Apr 2021 Page 1/2 Properties and test methodsUnitValueSpecific surface area (BET)m2/g175 - 225pH valuetested according to Ph. Eur., USP/NF, IP** - on drying (moisture)tested according to Ph. Eur., USP/NF, JP % density*g/lapprox. 50 SiO2 contenttested acc. to Ph. Eur., USP/NF, JP, IP** % contenttested according to JP passFe contenttested according to JP ppm 500Ca contenttested according to JP passAs contenttested according to USP/NF, IP**; JP according to Ph. Eur., IP**; JP ppm 250/ 110 Heavy Metalstested according to IP**; JP ppm 25/ 40 IPEC-GMP Yes* ex plant ** for Rheinfelden and Antwerp products only Characteristic physico-chemical data AEROSIL 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph.)
Characteristic physico-chemical data AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products which fulfils the analytical requirements of the currently valid ... www.silica-specialist.com ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}